Placebo and nocebo responses in other movement disorders besides Parkinson's disease: How much do we know?

Movement Disorders : Official Journal of the Movement Disorder Society
Joaquim J FerreiraTiago A Mestre

Abstract

Among movement disorders and medicine in general, PD is one of the conditions for which there is a greater knowledge of the placebo and nocebo responses. In other movement disorders, the knowledge of placebo and nocebo responses is less. An advance in this field is expected to contribute to a better understanding of the nature of a therapeutic benefit in clinical research and clinical practice, and mechanisms of placebo and nocebo. We conducted a review on placebo and nocebo responses in other movement disorders besides PD by primarily examining meta-analyses of clinical trials assessing specifically the placebo and/or nocebo responses. Second, we examined both efficacy and safety results of a placebo arm in pivotal placebo-controlled trials for the different movement disorders. RLS is the movement disorder for which the most data exist, followed by tic disorders and Huntington's disease. Data available in other conditions document a placebo response in a varied phenomenology. We found different placebo responses according to clinical domains assessed, type of outcomes used for the same clinical domain, and modes of treatment administration, including rehabilitation and surgical interventions. Data on the nocebo response were v...Continue Reading

References

Feb 19, 2000·Neurology·C G GoetzG T Stebbins
Mar 10, 2001·The New England Journal of Medicine·C R FreedS Fahn
Aug 11, 2001·Science·R de la Fuente-FernándezA J Stoessl
Mar 29, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Christopher G GoetzUNKNOWN Parkinson Study Group
Mar 1, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Daniel TruongGeoffrey L Sheean
Jul 29, 2005·Journal of Neural Transmission·F GeserUNKNOWN EMSA-SG
May 25, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Rodrigo MercadoChristopher R Honey
Nov 15, 2006·Neurology·D L GilbertF R Sallee
May 1, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Björn HolmbergUNKNOWN European MSA Study Group
Aug 19, 2007·Annals of Neurology·G Bernhard LandwehrmeyerUNKNOWN European Huntington's Disease Initiative Study Group
Oct 13, 2007·Brain : a Journal of Neurology·Stephany Fulda, Thomas C Wetter
Dec 18, 2007·Parkinsonism & Related Disorders·Mark Stacy, Dee Silver
Mar 8, 2008·Parkinsonism & Related Disorders·Daniel TruongUNKNOWN Dysport Benign Essential Blepharospasm Study Group
Dec 17, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Richard DodelKarla Eggert
Jan 30, 2010·Parkinsonism & Related Disorders·Raúl de la Fuente-Fernández
Feb 10, 2010·Archives of Neurology·Karl KieburtzUNKNOWN Huntington Disease Study Group DIMOND Investigators
Jan 25, 2011·Lancet Neurology·Günther DeuschlRodger Elble
Mar 30, 2011·European Child & Adolescent Psychiatry·Danielle C CathUNKNOWN ESSTS Guidelines Group
May 31, 2011·Patient Education and Counseling·Fabrizio Benedetti, Martina Amanzio
Dec 14, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Esther CuboUNKNOWN European Huntington's Disease Initiative Study Group
Apr 28, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R de la Fuente-Fernández
Jul 26, 2012·Annals of Neurology·Phil Hyu LeeYoung H Sohn
Jul 26, 2012·Annals of Neurology·Etsuro MoriUNKNOWN Donepezil-DLB Study Investigators
Oct 31, 2012·JAMA Neurology·UNKNOWN HORIZON Investigators of the Huntington Study Group and European Huntington's Disease Network
Jan 16, 2013·The American Journal of Psychiatry·Bret R Rutherford, Steven P Roose
Feb 15, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Esther CuboKatie Kompoliti
Jan 25, 2014·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Elisa FrisaldiFabrizio Benedetti
Feb 18, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Eduardo TolosaUNKNOWN TAUROS Investigators
Aug 16, 2014·Lancet Neurology·Jens VolkmannUNKNOWN DBS study group for dystonia
Dec 17, 2014·Molecular Psychiatry·M Peciña, J-K Zubieta
Feb 26, 2015·Alzheimer's Research & Therapy·Manabu IkedaKenji Kosaka
Oct 9, 2015·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·William G OndoThomas Roth
Mar 8, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Maria StamelouUNKNOWN AL-108-231 Investigators, Tauros Investigators, and MDS-Endorsed PSP Study Group

❮ Previous
Next ❯

Citations

Jan 2, 2022·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Zi-Xuan WangJie Song

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Tiago A MestreAnthony E Lang
Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Zhong-lin LiuEn-xiang Tao
Movement Disorders : Official Journal of the Movement Disorder Society
Tiago A MestreMichael S Okun
Movement Disorders : Official Journal of the Movement Disorder Society
Benzi M KlugerJoseph Jankovic
© 2022 Meta ULC. All rights reserved